Search Results - "Wiktorowicz, Tatiana"

  • Showing 1 - 20 results of 20
Refine Results
  1. 1

    Targeting deregulated AMPK/mTORC1 pathways improves muscle function in myotonic dystrophy type I by Brockhoff, Marielle, Rion, Nathalie, Chojnowska, Kathrin, Wiktorowicz, Tatiana, Eickhorst, Christopher, Erne, Beat, Frank, Stephan, Angelini, Corrado, Furling, Denis, Rüegg, Markus A, Sinnreich, Michael, Castets, Perrine

    Published in The Journal of clinical investigation (01-02-2017)
    “…Myotonic dystrophy type I (DM1) is a disabling multisystemic disease that predominantly affects skeletal muscle. It is caused by expanded CTG repeats in the…”
    Get full text
    Journal Article
  2. 2

    Heparan Sulfate Is an Attachment Factor for Foamy Virus Entry by PLOCHMANN, Kathrin, HORN, Anne, SCHELLER, Carsten, GSCHMACK, Eva, ARMBRUSTER, Nicole, KRIEG, Jennifer, WIKTOROWICZ, Tatiana, WEBER, Conrad, STIRNNAGEL, Kristin, LINDEMANN, Dirk, RETHWILM, Axel

    Published in Journal of Virology (01-09-2012)
    “…Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
    Get full text
    Journal Article
  3. 3

    Basic Residues in the Foamy Virus Gag Protein by MATTHES, Daniel, WIKTOROWICZ, Tatiana, ZAHN, Juliane, BODEM, Jochen, STANKE, Nicole, LINDEMANN, Dirk, RETHWILM, Axel

    Published in Journal of Virology (01-04-2011)
    “…Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
    Get full text
    Journal Article
  4. 4

    RNA and Protein Requirements for Incorporation of the Pol Protein into Foamy Virus Particles by PETERS, Katrin, WIKTOROWICZ, Tatiana, HEINKELEIN, Martin, RETHWILM, Axel

    Published in Journal of Virology (01-06-2005)
    “…Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Accuracy estimation of foamy virus genome copying by Gärtner, Kathleen, Wiktorowicz, Tatiana, Park, Jeonghae, Mergia, Ayalew, Rethwilm, Axel, Scheller, Carsten

    Published in Retrovirology (06-04-2009)
    “…Foamy viruses (FVs) are the most genetically stable viruses of the retrovirus family. This is in contrast to the in vitro error rate found for recombinant FV…”
    Get full text
    Journal Article
  7. 7

    No Evidence for Ceftobiprole-Induced Immune Hemolytic Anemia in Three Phase 3 Clinical Trials by Hamed, Kamal, Wiktorowicz, Tatiana, Gehr, Maziar Assadi

    Published in Infection and drug resistance (30-09-2020)
    “…Purpose: Drug-induced immune hemolytic anemia (DIIHA) is a rare but serious adverse event associated with a number of drugs, including second- and…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Identification of Plant-derived Alkaloids with Therapeutic Potential for Myotonic Dystrophy Type I by Herrendorff, Ruben, Faleschini, Maria Teresa, Stiefvater, Adeline, Erne, Beat, Wiktorowicz, Tatiana, Kern, Frances, Hamburger, Matthias, Potterat, Olivier, Kinter, Jochen, Sinnreich, Michael

    Published in The Journal of biological chemistry (12-08-2016)
    “…Myotonic dystrophy type I (DM1) is a disabling neuromuscular disease with no causal treatment available. This disease is caused by expanded CTG trinucleotide…”
    Get full text
    Journal Article
  10. 10

    Interlaboratory Analysis of Isavuconazole Plasma Concentration Assays Among European Laboratories by Pea, Federico, Krause, Robert, Müller, Carsten, Hennart, Benjamin, Richardson, Malcolm, Meinitzer, Andreas, Wiesen, Martin H J, Wiktorowicz, Tatiana, Spickermann, Jochen, Henriksen, Anne S

    Published in Therapeutic drug monitoring (01-10-2019)
    “…Under certain circumstances, clinicians treating patients with isavuconazole for invasive aspergillosis or mucormycosis may use therapeutic drug monitoring…”
    Get full text
    Journal Article
  11. 11

    In vitro activity of ceftobiprole and comparator antibiotics against contemporary European isolates (2016–19) by Canton, Rafael, Hamed, Kamal, Wiktorowicz, Tatiana, Redder, Nowel, Jemmely, Noelle, Quevedo, Juan, Santerre Henriksen, Anne

    Published in JAC-antimicrobial resistance (01-04-2022)
    “…Abstract Objectives To evaluate the susceptibility to ceftobiprole of clinical bacterial isolates obtained from hospitalized patients in Europe. Methods A…”
    Get full text
    Journal Article
  12. 12

    No Evidence for Ceftobiprole-Induced Immune Hemolytic Anemia in Three Phase 3 Clinical Trials by Hamed, Kamal, Wiktorowicz, Tatiana, Assadi Gehr, Maziar

    Published in Infection and drug resistance (01-01-2020)
    “…Drug-induced immune hemolytic anemia (DIIHA) is a rare but serious adverse event associated with a number of drugs, including second- and third-generation…”
    Get full text
    Journal Article
  13. 13

    No Evidence for Ceftobiprole-Induced Immune Hemolytic Anemia in Three Phase 3 Clinical Trials [Erratum] by Hamed, Kamal, Wiktorowicz, Tatiana, Assadi Gehr, Maziar

    Published in Infection and drug resistance (01-10-2020)
    “…Hamed K, Wiktorowicz T, Assadi Gehr M. Infect DrugResist. 2020;13:3209- 3215. The authors have advised that the Funding statement wasmissing on page 3214 of…”
    Get full text
    Journal Article
  14. 14

    Generation of an improved foamy virus vector by dissection of cis-acting sequences by Wiktorowicz, Tatiana, Peters, Katrin, Armbruster, Nicole, Steinert, Andre F, Rethwilm, Axel

    Published in Journal of general virology (01-02-2009)
    “…1 Universität Würzburg, Institut für Virologie und Immunbiologie, Würzburg, Germany 2 University of California, International Laboratory of Molecular Biology…”
    Get full text
    Journal Article
  15. 15

    Genetic characterization and improved genotyping of the dysferlin-deficient mouse strain Dysf (tm1Kcam) by Wiktorowicz, Tatiana, Kinter, Jochen, Kobuke, Kazuhiro, Campbell, Kevin P, Sinnreich, Michael

    Published in Skeletal muscle (13-10-2015)
    “…Mouse models of dysferlinopathies are valuable tools with which to investigate the pathomechanisms underlying these diseases and to test novel therapeutic…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Inter-laboratory analysis of Isavuconazole plasma concentration assays among European laboratories by Pea, Federico, Krause, Robert, Müller, Carsten, Hennart, Benjamin, Richardson, Malcolm, Meinitzer, Andreas, Wiesen, Martin H J, Wiktorowicz, Tatiana, Spickermann, Jochen, Henriksen, Anne Santerre

    Published in Therapeutic drug monitoring (31-03-2019)
    “…Under certain circumstances, clinicians treating patients with isavuconazole for invasive aspergillosis or mucormycosis may use therapeutic drug monitoring…”
    Get full text
    Journal Article
  18. 18
  19. 19

    AZT-resistant foamy virus by Kretzschmar, Benedikt, Nowrouzi, Ali, Hartl, Maximilian J, Gärtner, Kathleen, Wiktorowicz, Tatiana, Herchenröder, Ottmar, Kanzler, Sylvia, Rudolph, Wolfram, Mergia, Ayalew, Wöhrl, Birgitta, Rethwilm, Axel

    Published in Virology (New York, N.Y.) (05-01-2008)
    “…Abstract Azidothymidine (AZT) is a reverse transcriptase (RT) inhibitor that efficiently blocks the replication of spumaretroviruses or foamy viruses (FVs). To…”
    Get full text
    Journal Article
  20. 20

    New methods of pathogenic bacteria elimination by Wolska, Krystyna I, Kraczkiewicz-Dowjat, Anna, Grudniak, Anna M, Sajkowska, Anna, Wiktorowicz, Tatiana

    Published in Polish journal of microbiology (2004)
    “…The growing bacterial resistance to antibiotics calls for the elaboration of new pathogens elimination strategies. Some of these methods are based on the…”
    Get full text
    Journal Article